Several GLP-1R peptide-based agonists including liraglutide, semaglutide, dulaglutide, and tirzepatide (a dual GLP-1R/GIPR agonist) have been approved for the treatment of obesity and type 2 diabetes, achieving unprecedented improvements in glycemic control and body weight reduction (Arslanian et al., 2022
Immune System Support : Maintaining balanced levels of antioxidants can be beneficial for overall immune health 2
In Do-Wan et al.s study, they found that ROS production induced by fine particulate matter (PM) could be inhibited by TC since the presented quercetin, kaempferol, and chlorogenic acid [53]
The animals were housed on a 12-h light/dark cycle
The interaction of nutrients with the small and large intestine generates feedback that slows gastric emptying, induces satiation, and reduces postprandial glycemic excursions